US Patent Issued to Solvonics Therapeutics Ireland Holdings on March 31 for "Short-acting monoamine releasers" (British Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,077, issued on March 31, was assigned to Solvonics Therapeutics Ireland Holdings Ltd. (Dublin).

"Short-acting monoamine releasers" was invented by David Nutt (London), Alan Borthwick (London) and Robin Tyacke (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are novel 1,3-benzodioxole esters and their homologues, having various advantages over current compounds used in certain methods of drug-assisted therapy, such as MDMA, together with pharmaceutical compositions containing such 1,3-benzodioxole esters, and methods of their use to treat CNS disorders, and in particular mental health disorders."

The patent was filed on Jan. ...